The Matrix Metalloproteinase 9 Point-of-Care Test in Dry Eye

Nicole L. Lanza, Felipe Valenzuela, Victor L Perez Quinones, Anat Galor

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Dry eye is a common, multifactorial disease currently diagnosed by a combination of symptoms and signs. However, the subjective symptoms of dry eye poorly correlate to the current gold standard for diagnostic tests, reflecting the need to develop better objective tests for the diagnosis of dry eye. This review considers the role of ocular surface matrix metalloproteinase 9 (MMP-9) in dry eye and the implications of a novel point-of-care test that measures MMP-9 levels, InflammaDry (RPS, Sarasota, FL) on choosing appropriate therapeutic treatments.

Original languageEnglish (US)
Pages (from-to)189-195
Number of pages7
JournalOcular Surface
Volume14
Issue number2
DOIs
StatePublished - Apr 1 2016

Fingerprint

Point-of-Care Systems
Matrix Metalloproteinase 9
Routine Diagnostic Tests
Signs and Symptoms

Keywords

  • dry eye
  • InflammaDry
  • matrix metalloproteinase 9

ASJC Scopus subject areas

  • Ophthalmology

Cite this

The Matrix Metalloproteinase 9 Point-of-Care Test in Dry Eye. / Lanza, Nicole L.; Valenzuela, Felipe; Perez Quinones, Victor L; Galor, Anat.

In: Ocular Surface, Vol. 14, No. 2, 01.04.2016, p. 189-195.

Research output: Contribution to journalArticle

Lanza, NL, Valenzuela, F, Perez Quinones, VL & Galor, A 2016, 'The Matrix Metalloproteinase 9 Point-of-Care Test in Dry Eye', Ocular Surface, vol. 14, no. 2, pp. 189-195. https://doi.org/10.1016/j.jtos.2015.10.004
Lanza, Nicole L. ; Valenzuela, Felipe ; Perez Quinones, Victor L ; Galor, Anat. / The Matrix Metalloproteinase 9 Point-of-Care Test in Dry Eye. In: Ocular Surface. 2016 ; Vol. 14, No. 2. pp. 189-195.
@article{0d4831f7529442d9b2973e8967cae94b,
title = "The Matrix Metalloproteinase 9 Point-of-Care Test in Dry Eye",
abstract = "Dry eye is a common, multifactorial disease currently diagnosed by a combination of symptoms and signs. However, the subjective symptoms of dry eye poorly correlate to the current gold standard for diagnostic tests, reflecting the need to develop better objective tests for the diagnosis of dry eye. This review considers the role of ocular surface matrix metalloproteinase 9 (MMP-9) in dry eye and the implications of a novel point-of-care test that measures MMP-9 levels, InflammaDry (RPS, Sarasota, FL) on choosing appropriate therapeutic treatments.",
keywords = "dry eye, InflammaDry, matrix metalloproteinase 9",
author = "Lanza, {Nicole L.} and Felipe Valenzuela and {Perez Quinones}, {Victor L} and Anat Galor",
year = "2016",
month = "4",
day = "1",
doi = "10.1016/j.jtos.2015.10.004",
language = "English (US)",
volume = "14",
pages = "189--195",
journal = "Ocular Surface",
issn = "1542-0124",
publisher = "Ethis Communications, Inc.",
number = "2",

}

TY - JOUR

T1 - The Matrix Metalloproteinase 9 Point-of-Care Test in Dry Eye

AU - Lanza, Nicole L.

AU - Valenzuela, Felipe

AU - Perez Quinones, Victor L

AU - Galor, Anat

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Dry eye is a common, multifactorial disease currently diagnosed by a combination of symptoms and signs. However, the subjective symptoms of dry eye poorly correlate to the current gold standard for diagnostic tests, reflecting the need to develop better objective tests for the diagnosis of dry eye. This review considers the role of ocular surface matrix metalloproteinase 9 (MMP-9) in dry eye and the implications of a novel point-of-care test that measures MMP-9 levels, InflammaDry (RPS, Sarasota, FL) on choosing appropriate therapeutic treatments.

AB - Dry eye is a common, multifactorial disease currently diagnosed by a combination of symptoms and signs. However, the subjective symptoms of dry eye poorly correlate to the current gold standard for diagnostic tests, reflecting the need to develop better objective tests for the diagnosis of dry eye. This review considers the role of ocular surface matrix metalloproteinase 9 (MMP-9) in dry eye and the implications of a novel point-of-care test that measures MMP-9 levels, InflammaDry (RPS, Sarasota, FL) on choosing appropriate therapeutic treatments.

KW - dry eye

KW - InflammaDry

KW - matrix metalloproteinase 9

UR - http://www.scopus.com/inward/record.url?scp=84963956637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963956637&partnerID=8YFLogxK

U2 - 10.1016/j.jtos.2015.10.004

DO - 10.1016/j.jtos.2015.10.004

M3 - Article

C2 - 26850527

AN - SCOPUS:84963956637

VL - 14

SP - 189

EP - 195

JO - Ocular Surface

JF - Ocular Surface

SN - 1542-0124

IS - 2

ER -